We provide you with 20 years of free, institutional-grade data for SRPT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SRPT. Explore the full financial landscape of SRPT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$5,369
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Rodino-Klapac Louise | Grant, award...etc | 143,875 | 2025-09-05 | ||
| Wong Ryan Ho-Yan | Grant, award...etc | 118,875 | 2025-09-05 | ||
| Estepan Ian Michael | Grant, award...etc | 143,875 | 2025-09-05 | ||
| Rothfuss Cristin | Grant, award...etc | 118,875 | 2025-09-05 | ||
| Wong Ryan Ho-Yan | Initial | 2025-08-04 | |||
| Wong Ryan Ho-Yan | Sale | -327 | $16.42 | $5,369 | 2025-08-04 |
| Barry Richard | Derivatives Exercise | 12,350 | 2025-05-19 | ||
| Barry Richard | Derivatives Exercise | 20,246 | 2025-05-15 | ||
| Nicaise Claude | Sale | -2,491 | $99.64 | $248,203 | 2025-03-13 |
| Nicaise Claude | Derivatives Exercise | 9,746 | 2025-03-13 | ||
| Chambers Michael Andrew | Grant, award...etc | 2,383 | 2025-03-11 | ||
| Rothfuss Cristin | Grant, award...etc | 8,276 | 2025-03-11 | ||
| Rothfuss Cristin | Sale | -491 | $100.13 | $49,164 | 2025-03-11 |
| Estepan Ian Michael | Grant, award...etc | 8,276 | 2025-03-11 | ||
| Estepan Ian Michael | Sale | -3,941 | $100.13 | $394,612 | 2025-03-11 |
| Estepan Ian Michael | Derivatives Exercise | 5,500 | 2025-03-11 | ||
| Wigzell Hans Lennart Rudolf | Grant, award...etc | 2,383 | 2025-03-11 | ||
| Mayo Stephen | Grant, award...etc | 2,383 | 2025-03-11 | ||
| Arif Bilal | Grant, award...etc | 8,276 | 2025-03-11 | ||
| Arif Bilal | Sale | -523 | $100.13 | $52,368 | 2025-03-11 |
| Rodino-Klapac Louise | Grant, award...etc | 8,276 | 2025-03-11 | ||
| Rodino-Klapac Louise | Sale | -3,463 | $100.13 | $346,750 | 2025-03-11 |
| Rodino-Klapac Louise | Derivatives Exercise | 5,500 | 2025-03-11 | ||
| Murray Dallan | Grant, award...etc | 8,276 | 2025-03-11 | ||
| Murray Dallan | Sale | -3,733 | $100.13 | $373,785 | 2025-03-11 |
| Murray Dallan | Derivatives Exercise | 5,500 | 2025-03-11 | ||
| Barry Richard | Grant, award...etc | 2,383 | 2025-03-11 | ||
| Nicaise Claude | Grant, award...etc | 2,383 | 2025-03-11 | ||
| BEHRENS M KATHLEEN | Grant, award...etc | 2,383 | 2025-03-11 | ||
| Connelly Deirdre P | Grant, award...etc | 2,383 | 2025-03-11 | ||
| Boor Kathryn Jean | Grant, award...etc | 2,383 | 2025-03-11 | ||
| Estepan Ian Michael | Sale | -9,679 | $103.7 | $1,003,712 | 2025-03-10 |
| Estepan Ian Michael | Derivatives Exercise | 17,500 | 2025-03-10 | ||
| Rodino-Klapac Louise | Sale | -8,504 | $103.7 | $881,865 | 2025-03-10 |
| Rodino-Klapac Louise | Derivatives Exercise | 17,500 | 2025-03-10 | ||
| Rothfuss Cristin | Sale | -1,478 | $103.7 | $153,269 | 2025-03-10 |
| Murray Dallan | Sale | -9,162 | $103.7 | $950,099 | 2025-03-10 |
| Murray Dallan | Derivatives Exercise | 17,500 | 2025-03-10 | ||
| Arif Bilal | Sale | -9,035 | $103.7 | $936,930 | 2025-03-10 |
| Arif Bilal | Derivatives Exercise | 17,500 | 2025-03-10 | ||
| Rodino-Klapac Louise | Sale | -1,704 | $101.34 | $172,683 | 2025-03-06 |
| Murray Dallan | Sale | -1,685 | $101.34 | $170,758 | 2025-03-06 |
| Arif Bilal | Sale | -514 | $101.34 | $52,089 | 2025-03-06 |
| Estepan Ian Michael | Sale | -1,370 | $101.34 | $138,836 | 2025-03-06 |
| Rothfuss Cristin | Sale | -584 | $101.34 | $59,183 | 2025-03-06 |
| Rothfuss Cristin | Sale | -391 | $103.77 | $40,574 | 2025-03-04 |
| Estepan Ian Michael | Sale | -557 | $103.77 | $57,800 | 2025-03-04 |
| Rodino-Klapac Louise | Sale | -715 | $103.77 | $74,196 | 2025-03-04 |
| Murray Dallan | Sale | -711 | $103.77 | $73,780 | 2025-03-04 |
| Arif Bilal | Sale | -719 | $103.77 | $74,611 | 2025-03-04 |
| Estepan Ian Michael | Sale | -2,613 | $117.51 | $307,054 | 2025-01-31 |
| Estepan Ian Michael | Derivatives Exercise | 15,800 | 2025-01-31 | ||
| Wigzell Hans Lennart Rudolf | Sale | -10,500 | $124.84 | $1,310,820 | 2024-12-16 |
| Wigzell Hans Lennart Rudolf | Derivatives Exercise | 10,500 | 2024-12-16 | ||
| Boor Kathryn Jean | Sale | -1,636 | $125.55 | $205,400 | 2024-12-06 |
| Rothfuss Cristin | Grant, award...etc | 2,000 | 2024-11-29 | ||
| Rothfuss Cristin | Initial | 2024-11-29 | |||
| Rodino-Klapac Louise | Sale | -4,558 | $102.89 | $468,973 | 2024-11-20 |
| Connelly Deirdre P | Grant, award...etc | 2,842 | 2024-09-16 | ||
| Estepan Ian Michael | Sale | -5,985 | $137.36 | $822,100 | 2024-09-03 |
| Chambers Michael Andrew | Open Market Purchase | 37,038 | $133.07 | 2024-08-20 | |
| BEHRENS M KATHLEEN | Derivatives Exercise | 15,000 | 2024-07-08 | ||
| Arif Bilal | Sale | -14,109 | $164.64 | $2,322,906 | 2024-06-25 |
| Arif Bilal | Derivatives Exercise | 6,250 | 2024-06-25 | ||
| Brown Ryan Edward | Sale | -41,309 | $164.64 | $6,801,114 | 2024-06-25 |
| Brown Ryan Edward | Derivatives Exercise | 29,750 | 2024-06-25 | ||
| Rodino-Klapac Louise | Sale | -2,182 | $164.64 | $359,244 | 2024-06-25 |
| Rodino-Klapac Louise | Derivatives Exercise | 6,250 | 2024-06-25 | ||
| Estepan Ian Michael | Sale | -2,483 | $164.64 | $408,801 | 2024-06-25 |
| Estepan Ian Michael | Derivatives Exercise | 6,250 | 2024-06-25 | ||
| Murray Dallan | Sale | -2,352 | $164.64 | $387,233 | 2024-06-25 |
| Murray Dallan | Derivatives Exercise | 6,250 | 2024-06-25 | ||
| Murray Dallan | Initial | 2024-05-06 | |||
| Murray Dallan | Sale | -3,635 | $140 | $508,900 | 2024-05-06 |
| Estepan Ian Michael | Sale | -1,561 | $120.49 | $188,085 | 2024-03-11 |
| Brown Ryan Edward | Sale | -1,405 | $120.49 | $169,288 | 2024-03-11 |
| Rodino-Klapac Louise | Sale | -1,421 | $120.49 | $171,216 | 2024-03-11 |
| Wigzell Hans Lennart Rudolf | Sale | -15,000 | $123.85 | $1,857,750 | 2024-03-11 |
| Wigzell Hans Lennart Rudolf | Derivatives Exercise | 15,000 | 2024-03-11 | ||
| Boor Kathryn Jean | Sale | -761 | $122.93 | $93,550 | 2024-03-11 |
| Arif Bilal | Sale | -978 | $120.49 | $117,839 | 2024-03-11 |
| Rodino-Klapac Louise | Sale | -1,728 | $125.32 | $216,553 | 2024-03-06 |
| Arif Bilal | Sale | -522 | $125.32 | $65,417 | 2024-03-06 |
| Brown Ryan Edward | Sale | -1,734 | $125.32 | $217,305 | 2024-03-06 |
| Estepan Ian Michael | Sale | -1,389 | $125.32 | $174,069 | 2024-03-06 |
| Mayo Stephen | Sale | -3,135 | $122.96 | $385,480 | 2024-03-06 |
| Nicaise Claude | Grant, award...etc | 1,846 | 2024-03-05 | ||
| Mayo Stephen | Grant, award...etc | 1,846 | 2024-03-05 | ||
| Wigzell Hans Lennart Rudolf | Grant, award...etc | 1,846 | 2024-03-05 | ||
| Chambers Michael Andrew | Grant, award...etc | 1,846 | 2024-03-05 | ||
| Arif Bilal | Grant, award...etc | 6,000 | 2024-03-05 | ||
| Arif Bilal | Sale | -2,365 | $126.19 | $298,439 | 2024-03-05 |
| BEHRENS M KATHLEEN | Grant, award...etc | 1,846 | 2024-03-05 | ||
| Estepan Ian Michael | Grant, award...etc | 6,000 | 2024-03-05 | ||
| Estepan Ian Michael | Sale | -1,565 | $126.19 | $197,487 | 2024-03-05 |
| Boor Kathryn Jean | Grant, award...etc | 1,846 | 2024-03-05 | ||
| Barry Richard | Grant, award...etc | 1,846 | 2024-03-05 | ||
| Brown Ryan Edward | Grant, award...etc | 6,000 | 2024-03-05 | ||
| Brown Ryan Edward | Sale | -2,269 | $126.19 | $286,325 | 2024-03-05 |
| Rodino-Klapac Louise | Grant, award...etc | 6,000 | 2024-03-05 | ||
| Rodino-Klapac Louise | Sale | -778 | $126.19 | $98,176 | 2024-03-05 |
| Arif Bilal | Sale | -3,682 | $80.34 | $295,812 | 2023-12-05 |
| Rodino-Klapac Louise | Sale | -4,508 | $82.98 | $374,074 | 2023-11-20 |
| BEHRENS M KATHLEEN | Derivatives Exercise | 15,000 | 2023-11-06 | ||
| Barry Richard | Open Market Purchase | 40,000 | $78.81 | 2023-11-06 | |
| Barry Richard | Open Market Purchase | 10,000 | $78.81 | 2023-11-06 | |
| INGRAM DOUGLAS S | Open Market Purchase | 25,225 | $78.57 | 2023-11-06 | |
| Chambers Michael Andrew | Open Market Purchase | 9,979 | $109.19 | 2023-08-15 | |
| Chambers Michael Andrew | Open Market Purchase | 23,686 | $108.05 | 2023-08-14 | |
| Chambers Michael Andrew | Open Market Purchase | 34,867 | $104.67 | 2023-08-11 | |
| Wigzell Hans Lennart Rudolf | Sale | -15,000 | $106.72 | $1,600,800 | 2023-08-08 |
| Wigzell Hans Lennart Rudolf | Derivatives Exercise | 15,000 | 2023-08-08 | ||
| Brown Ryan Edward | Sale | -89 | $123.6 | $11,000 | 2023-06-05 |
| Arif Bilal | Sale | -307 | $136.66 | $41,955 | 2023-04-04 |
| Brown Ryan Edward | Sale | -635 | $153.19 | $97,276 | 2023-03-10 |
| Arif Bilal | Sale | -314 | $153.19 | $48,102 | 2023-03-10 |
| Rodino-Klapac Louise | Sale | -912 | $153.19 | $139,709 | 2023-03-10 |
| Estepan Ian Michael | Sale | -744 | $153.19 | $113,973 | 2023-03-10 |
| Wigzell Hans Lennart Rudolf | Grant, award...etc | 1,523 | 2023-03-08 | ||
| Arif Bilal | Grant, award...etc | 4,500 | 2023-03-08 | ||
| Arif Bilal | Sale | -340 | $157.21 | $53,451 | 2023-03-08 |
| BEHRENS M KATHLEEN | Grant, award...etc | 1,523 | 2023-03-08 | ||
| Estepan Ian Michael | Grant, award...etc | 4,500 | 2023-03-08 | ||
| Estepan Ian Michael | Sale | -1,370 | $157.21 | $215,378 | 2023-03-08 |
| Barry Richard | Grant, award...etc | 1,523 | 2023-03-08 | ||
| Rodino-Klapac Louise | Grant, award...etc | 4,500 | 2023-03-08 | ||
| Rodino-Klapac Louise | Sale | -1,134 | $157.21 | $178,276 | 2023-03-08 |
| Brown Ryan Edward | Grant, award...etc | 4,500 | 2023-03-08 | ||
| Brown Ryan Edward | Sale | -1,325 | $157.21 | $208,303 | 2023-03-08 |
| Chambers Michael Andrew | Grant, award...etc | 1,523 | 2023-03-08 | ||
| Nicaise Claude | Grant, award...etc | 1,523 | 2023-03-08 | ||
| Boor Kathryn Jean | Grant, award...etc | 1,523 | 2023-03-08 | ||
| Mayo Stephen | Grant, award...etc | 1,523 | 2023-03-08 | ||
| Rodino-Klapac Louise | Sale | -522 | $147.57 | $77,032 | 2023-03-03 |
| Arif Bilal | Sale | -252 | $147.57 | $37,188 | 2023-03-03 |
| Estepan Ian Michael | Sale | -378 | $147.57 | $55,781 | 2023-03-03 |
| Brown Ryan Edward | Sale | -196 | $147.57 | $28,924 | 2023-03-03 |
| Arif Bilal | Initial | 2023-01-04 | |||
| BEHRENS M KATHLEEN | Derivatives Exercise | 20,000 | 2022-12-21 | ||
| Mayo Stephen | Sale | -858 | $109.92 | $94,311 | 2022-11-21 |
The information provided in this report about SRPT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sarepta Therapeutics (NASDAQ:SRPT)Â 
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscul...
Website: http://www.sarepta.com
Founded: 1980
Full Time Employees: 743
Sector: Healthcare
Industry: Biotechnology